Presented By Horizon CME

Insights from the 68th ASH Annual Meeting - Boston

The Westin Waltham Boston

February 6th - 7th

Join us in Boston (Waltham) for Insights from the 68th ASH Annual Meeting Feb 6 - 7!

Insights from the 68th ASH Annual Meeting, an independent review of the ASH Annual Meeting, is a two-day program designed to provide the latest science and education from the world’s premier hematology event. The abstracts selected for presentation and discussion reflect the foremost research, insights, and advances in hematology that will impact clinical practice and patient care.

The program features in-depth discussions and analyses of the latest scientific findings in blood disorders and cancers, as well as practice-changing advances in treatment. Expert faculty will review the findings, discuss their potential impact on the current standard of care, and apply the results within the clinical context of a patient case.

Intended Learners: The educational activity is intended for hematologists/oncologists, medical oncologists, oncology NPs/PAs, pharmacists, nurses, and other healthcare professionals who treat patients with hematologic disorders.

Register Today!

EARLY BIRD (THROUGH NOV 6, 2026)

Physicians: $100

Pharmacists: $50

NP - PA: $50

RN & Others: $50

Students - Fellows: $0 (See Registration Page for Details)

Pharma / Med Device Company Employee: $500 (See Registration Page for Details)

ADVANCED (THROUGH JAN 6)

Physicians: $125

Pharmacists: $75

NP - PA: $75

RN & Others: $75

Students - Fellows: $0 (See Registration Page for Details)

Pharma / Med Device Company Employee: $525 (See Registration Page for Details)

GENERAL REGISTRATION

Physicians: $175

Pharmacists: $125

NP - PA: $125

RN & Others: $125

Students - Fellows: $0 (See Registration Page for Details)

Pharma / Med Device Company Employee: $575 (See Registration Page for Details)

GO HERE TO REGISTER

Conference Planning Committee

Omar Nadeem, MD

Senior Physician, Clinical Dir. Myeloma Immune Effector Cell Therapy Program, Medical Dir. for the Center for Early Detection and Interception of Blood Cancers, Associate Dir. of the Myeloma Clinical Research Program, Dana-Farber Boston, MA

Amir Fathi, MD

Director, Leukemia Program, Professor of Medicine, Harvard Medical School, Massachusetts General Hospital Cambridge, MA

Andreas Klein, MD

Interim Chief, Division of Hematology/Oncology Tufts Medical Center Boston, MA

Jacalyn Rosenblatt, MD

Associate Professor of Medicine Harvard Medical School Boston, MA

J. Mark Sloan, MD

Clinical Professor of Medicine Boston University School of Medicine Boston, MA

Accommodations

The Westin Waltham Boston

We want to ensure that your time at the 2027 Insights from the 68th ASH Annual Meeting – Boston conference is convenient and memorable. Staying at our host hotel provides a hassle-free experience and puts you at the heart of the activity surrounding the conference.

Booking details to come